O
Osanni Bio
Biotech & Life Sciences · San Francisco, United States · Founded 2023
Therapies to prevent and reverse retinal disease blindness. MoreLess
Osanni Bio is a development-stage therapeutics platform headquartered in San Francisco, California, reinventing the discovery and development of new medicines. At its center is an innovation engine optimized for discovering new scientific insights, designing novel drug concepts, and efficiently advancing programs to a meaningful proof-of-concept. Its model pairs a centralised research engine with a network of affiliate companies; once a program is de-risked it graduates into its own focused entity to scale. Programs span ophthalmology and cardiology, with an emphasis on capital-efficient drug development.
Company overview
Osanni Bio company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2023
- Headquarters
- San Francisco, United States
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 22.3
Valuation & funding
Osanni Bio funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jun 2026 | $190M | $760M | Retinal Degeneration Fund · Horowitz Group · Invus Opportunities · Patient Square Capital | ↗ |
Growth signals
Osanni Bio website traffic
Latest recorded traffic for Osanni Bio is 180 monthly website visits.
Comparisons
Osanni Bio compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 Jerini Ophthalmic Inc.Peptide-based drug development for ophthalmic indications. |
— | Operational | 2 | — | — |
 OtusOphtaLipid-based technology for treating dry eye disease |
Helsinki, Finland | Operational | |||
 CuracleOral therapeutics for age-related intractable vascular diseases |
Seoul, South Korea | Operational | |||
 EclosixSpecialty oral suspension and tablet pharmaceuticals for patients. |
Milton Keynes, United Kingdom | Operational | |||
 EIT PharmaTherapies for serious and life-threatening viral diseases. |
Kirkland, United States | Operational | |||
 CardiaCuresSoftware-linked medicines for personalized cardiovascular dosing. |
— | Operational | |||
 Claveritas PharmaBiotech & Life Sciences |
— | Operational | |||
 Dimicare BiotechPrecision antibiotics for multidrug-resistant pathogens. |
Nice, France | Operational |
Talent graph
Osanni Bio's talent
Source: Dealroom Talent Intelligence.
Investors
4 investors on Osanni Bio's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Osanni Bio has talent and traffic
In the news
Latest news about Osanni Bio
Recent press, funding announcements, and product moves mentioning Osanni Bio — open to read from the original sources.
Market sentiment
What the market is saying about Osanni Bio
An AI-synthesized read of the highest-engagement posts about Osanni Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Osanni Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.